Table 2 Comparison of the areas under the receiver operating characteristics curves (AUCs) for percent changes of functional tumor volumes and tumor volume reduction for a subset of 90 patients

From: Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer

  

Mean ± SD (cm3)

 

DeLong’s test p-value

Cycle

Measurement

Non-pCR

(n = 45)

pCR

(n = 45)

AUC [95% CI]

2 cycles of NAST

Tumor volume reduction

37.33 ± 38.77

70.66 ± 26.34

0.80 [0.70-0.89]

0.67

Functional tumor volume reduction

44.62 ± 33.17

73.71 ± 26.16

0.79 [0.69-0.88]

4 cycles of NAST

Tumor volume reduction

60.74 ± 40.60

89.19 ± 20.44

0.81 [0.73-0.90]

0.85

Functional tumor volume reduction

70.15 ± 27.82

93.09 ± 12.20

0.82 [0.73-0.91]